GenoFocus, Inc. (KOSDAQ: 187420)
South Korea
· Delayed Price · Currency is KRW
4,055.00
0.00 (0.00%)
Nov 15, 2024, 9:00 AM KST
GenoFocus Company Description
GenoFocus, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally.
Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2.
The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, oral mucositis, nonalcoholic steatohepatitis, diabetic macular edema, and dry eye indications.
GenoFocus, Inc. was founded in 2000 and is based in Daejeon, South Korea.
GenoFocus, Inc.
Country | South Korea |
Founded | 2000 |
Industry | Industrial Organic Chemicals |
Employees | 68 |
CEO | Eui-Joong Kim |
Contact Details
Address: 65 Techno 1-ro Daejeon, 34014 South Korea | |
Phone | 82 4 2862 4483 |
Website | genofocus.com |
Stock Details
Ticker Symbol | 187420 |
Exchange | KOSDAQ |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2860 |
Key Executives
Name | Position |
---|---|
Eui-Joong Kim | Chief Executive Officer |